Hypophosphataemia following ferric carboxymaltose and ferric derisomaltose: case closed, but questions remain

Ayushi Chauhan¹, Sarah Lucas¹, Mayur Garg^{2

3}

Affiliations

¹ Department of Gastroenterology, Northern Health, Melbourne, Victoria, Australia.
² Department of Gastroenterology, Northern Health, Melbourne, Victoria, Australia mayur.garg@monash.edu.
³ Department of Medicine, The University of Melbourne, Melbourne, Victoria, Australia.

Case Reports

Ayushi Chauhan et al. Gut. 2024.

. 2024 May 10;73(6):1039.

doi: 10.1136/gutjnl-2023-330061.

Ayushi Chauhan¹, Sarah Lucas¹, Mayur Garg^{2

3}

¹ Department of Gastroenterology, Northern Health, Melbourne, Victoria, Australia.
² Department of Gastroenterology, Northern Health, Melbourne, Victoria, Australia mayur.garg@monash.edu.
³ Department of Medicine, The University of Melbourne, Melbourne, Victoria, Australia.

No abstract available

Keywords: INFLAMMATORY BOWEL DISEASE; IRON DEFICIENCY.

Conflict of interest statement

Competing interests: None declared.

Hypophosphataemia following ferric derisomaltose and ferric carboxymaltose in patients with iron deficiency anaemia due to inflammatory bowel disease (PHOSPHARE-IBD): a randomised clinical trial.
Zoller H, Wolf M, Blumenstein I, Primas C, Lindgren S, Thomsen LL, Reinisch W, Iqbal T. Zoller H, et al. Gut. 2023 Apr;72(4):644-653. doi: 10.1136/gutjnl-2022-327897. Epub 2022 Sep 9. Gut. 2023. PMID: 36343979 Free PMC article. Clinical Trial.